Ventricular fibrillation in the wolff-parkinson-white syndrome

P. Torner, P. Brugada, J. Smeets, M. Talajic, P. Della Bella, R. Lezaun, A. V d Dool, H. J J Wellens, A. Bayés De Luna, R. Oter, G. Breithardt, M. Borggrefe, H. Klein, K. H. Kuck, K. Kunze, P. Coumel, J. F. Leclercq, F. Chouty, R. Frank, G. Fontanine

Research output: Contribution to journalArticle

Abstract

Ventricular fibrillation (VF) is a well-known but rare complication of the Wolff-Parkinson-White syndrome (WPW). Clinical and electrophysiological data of 23 patients with spontaneous VF were compared with data from 100 consecutive patients with WPW without VF but with symptomatic supraventricular tachycardia. The 23 patients were collected in a multicentre retrospective study in seven European centres. VF occurred in only one patient who was receiving anti-arrhythmic drugs, and was the first manifestation of the syndrome in six. No significant differences were found between those with VF and without VF in age, complaints of palpitations, syncope, and presence of structural heart disease. The retrograde effective refractory period of the accessory pathway, the atrial refractory period and the fastest atrial pacing rate with 1: 1 anterograde conduction over the accessory pathway were similar in both groups. Significant differences were found for sex, permanent pre-excitation on the electrocardiogram, type of documented supraventricular t achy arrhythmias, shortest RR interval ≦220 ms during spontaneous atrial fibrillation (AF), inducibility of supraventricular tachycardias, ventricular effective refractory period ≦190 ms, mean shortest RR interval during induced AF ≦, 180 ms and presence of multiple accessory pathways. Data from this retrospective study indicate that: (1) the anterograde conduction properties of the accessory pathway are a major determinant of the occurrence of VF in the WPW syndrome; (2) other markers for risk of VF are type of previously documented supraventricular tachyarrhythmia, documentation of more than one type of supraventricular tachycardia in the same patient and presence of two or more accessory pathways; (3) the finding of intermittent pre-excitation and a shortest RR interval during spontaneous AF longer than 220 ms, identifies a group of patients at low risk of VF.

Original languageEnglish
Pages (from-to)144-150
Number of pages7
JournalEuropean Heart Journal
Volume12
Issue number2
Publication statusPublished - Feb 1991

Fingerprint

Ventricular Fibrillation
Wolff-Parkinson-White Syndrome
Accessories
Refractory materials
Pathway
Atrial Fibrillation
Supraventricular Tachycardia
Conduction
Interval
Electrocardiography
Retrospective Studies
Antiarrhythmic Drugs
Excitation
Ventricular Tachycardia
Fibrillation
Arrhythmia
Anti-Arrhythmia Agents
Syncope
Complications
Tachycardia

Keywords

  • Accessory pathway
  • Atrial fibrillation
  • Sudden cardiac death
  • Ventricular fibrillation
  • Wolff-Parkin son -White syndrome

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Torner, P., Brugada, P., Smeets, J., Talajic, M., Della Bella, P., Lezaun, R., ... Fontanine, G. (1991). Ventricular fibrillation in the wolff-parkinson-white syndrome. European Heart Journal, 12(2), 144-150.

Ventricular fibrillation in the wolff-parkinson-white syndrome. / Torner, P.; Brugada, P.; Smeets, J.; Talajic, M.; Della Bella, P.; Lezaun, R.; Dool, A. V d; Wellens, H. J J; De Luna, A. Bayés; Oter, R.; Breithardt, G.; Borggrefe, M.; Klein, H.; Kuck, K. H.; Kunze, K.; Coumel, P.; Leclercq, J. F.; Chouty, F.; Frank, R.; Fontanine, G.

In: European Heart Journal, Vol. 12, No. 2, 02.1991, p. 144-150.

Research output: Contribution to journalArticle

Torner, P, Brugada, P, Smeets, J, Talajic, M, Della Bella, P, Lezaun, R, Dool, AVD, Wellens, HJJ, De Luna, AB, Oter, R, Breithardt, G, Borggrefe, M, Klein, H, Kuck, KH, Kunze, K, Coumel, P, Leclercq, JF, Chouty, F, Frank, R & Fontanine, G 1991, 'Ventricular fibrillation in the wolff-parkinson-white syndrome', European Heart Journal, vol. 12, no. 2, pp. 144-150.
Torner P, Brugada P, Smeets J, Talajic M, Della Bella P, Lezaun R et al. Ventricular fibrillation in the wolff-parkinson-white syndrome. European Heart Journal. 1991 Feb;12(2):144-150.
Torner, P. ; Brugada, P. ; Smeets, J. ; Talajic, M. ; Della Bella, P. ; Lezaun, R. ; Dool, A. V d ; Wellens, H. J J ; De Luna, A. Bayés ; Oter, R. ; Breithardt, G. ; Borggrefe, M. ; Klein, H. ; Kuck, K. H. ; Kunze, K. ; Coumel, P. ; Leclercq, J. F. ; Chouty, F. ; Frank, R. ; Fontanine, G. / Ventricular fibrillation in the wolff-parkinson-white syndrome. In: European Heart Journal. 1991 ; Vol. 12, No. 2. pp. 144-150.
@article{d96ae19669c343ee8a6ffa2fb2dcef27,
title = "Ventricular fibrillation in the wolff-parkinson-white syndrome",
abstract = "Ventricular fibrillation (VF) is a well-known but rare complication of the Wolff-Parkinson-White syndrome (WPW). Clinical and electrophysiological data of 23 patients with spontaneous VF were compared with data from 100 consecutive patients with WPW without VF but with symptomatic supraventricular tachycardia. The 23 patients were collected in a multicentre retrospective study in seven European centres. VF occurred in only one patient who was receiving anti-arrhythmic drugs, and was the first manifestation of the syndrome in six. No significant differences were found between those with VF and without VF in age, complaints of palpitations, syncope, and presence of structural heart disease. The retrograde effective refractory period of the accessory pathway, the atrial refractory period and the fastest atrial pacing rate with 1: 1 anterograde conduction over the accessory pathway were similar in both groups. Significant differences were found for sex, permanent pre-excitation on the electrocardiogram, type of documented supraventricular t achy arrhythmias, shortest RR interval ≦220 ms during spontaneous atrial fibrillation (AF), inducibility of supraventricular tachycardias, ventricular effective refractory period ≦190 ms, mean shortest RR interval during induced AF ≦, 180 ms and presence of multiple accessory pathways. Data from this retrospective study indicate that: (1) the anterograde conduction properties of the accessory pathway are a major determinant of the occurrence of VF in the WPW syndrome; (2) other markers for risk of VF are type of previously documented supraventricular tachyarrhythmia, documentation of more than one type of supraventricular tachycardia in the same patient and presence of two or more accessory pathways; (3) the finding of intermittent pre-excitation and a shortest RR interval during spontaneous AF longer than 220 ms, identifies a group of patients at low risk of VF.",
keywords = "Accessory pathway, Atrial fibrillation, Sudden cardiac death, Ventricular fibrillation, Wolff-Parkin son -White syndrome",
author = "P. Torner and P. Brugada and J. Smeets and M. Talajic and {Della Bella}, P. and R. Lezaun and Dool, {A. V d} and Wellens, {H. J J} and {De Luna}, {A. Bay{\'e}s} and R. Oter and G. Breithardt and M. Borggrefe and H. Klein and Kuck, {K. H.} and K. Kunze and P. Coumel and Leclercq, {J. F.} and F. Chouty and R. Frank and G. Fontanine",
year = "1991",
month = "2",
language = "English",
volume = "12",
pages = "144--150",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Ventricular fibrillation in the wolff-parkinson-white syndrome

AU - Torner, P.

AU - Brugada, P.

AU - Smeets, J.

AU - Talajic, M.

AU - Della Bella, P.

AU - Lezaun, R.

AU - Dool, A. V d

AU - Wellens, H. J J

AU - De Luna, A. Bayés

AU - Oter, R.

AU - Breithardt, G.

AU - Borggrefe, M.

AU - Klein, H.

AU - Kuck, K. H.

AU - Kunze, K.

AU - Coumel, P.

AU - Leclercq, J. F.

AU - Chouty, F.

AU - Frank, R.

AU - Fontanine, G.

PY - 1991/2

Y1 - 1991/2

N2 - Ventricular fibrillation (VF) is a well-known but rare complication of the Wolff-Parkinson-White syndrome (WPW). Clinical and electrophysiological data of 23 patients with spontaneous VF were compared with data from 100 consecutive patients with WPW without VF but with symptomatic supraventricular tachycardia. The 23 patients were collected in a multicentre retrospective study in seven European centres. VF occurred in only one patient who was receiving anti-arrhythmic drugs, and was the first manifestation of the syndrome in six. No significant differences were found between those with VF and without VF in age, complaints of palpitations, syncope, and presence of structural heart disease. The retrograde effective refractory period of the accessory pathway, the atrial refractory period and the fastest atrial pacing rate with 1: 1 anterograde conduction over the accessory pathway were similar in both groups. Significant differences were found for sex, permanent pre-excitation on the electrocardiogram, type of documented supraventricular t achy arrhythmias, shortest RR interval ≦220 ms during spontaneous atrial fibrillation (AF), inducibility of supraventricular tachycardias, ventricular effective refractory period ≦190 ms, mean shortest RR interval during induced AF ≦, 180 ms and presence of multiple accessory pathways. Data from this retrospective study indicate that: (1) the anterograde conduction properties of the accessory pathway are a major determinant of the occurrence of VF in the WPW syndrome; (2) other markers for risk of VF are type of previously documented supraventricular tachyarrhythmia, documentation of more than one type of supraventricular tachycardia in the same patient and presence of two or more accessory pathways; (3) the finding of intermittent pre-excitation and a shortest RR interval during spontaneous AF longer than 220 ms, identifies a group of patients at low risk of VF.

AB - Ventricular fibrillation (VF) is a well-known but rare complication of the Wolff-Parkinson-White syndrome (WPW). Clinical and electrophysiological data of 23 patients with spontaneous VF were compared with data from 100 consecutive patients with WPW without VF but with symptomatic supraventricular tachycardia. The 23 patients were collected in a multicentre retrospective study in seven European centres. VF occurred in only one patient who was receiving anti-arrhythmic drugs, and was the first manifestation of the syndrome in six. No significant differences were found between those with VF and without VF in age, complaints of palpitations, syncope, and presence of structural heart disease. The retrograde effective refractory period of the accessory pathway, the atrial refractory period and the fastest atrial pacing rate with 1: 1 anterograde conduction over the accessory pathway were similar in both groups. Significant differences were found for sex, permanent pre-excitation on the electrocardiogram, type of documented supraventricular t achy arrhythmias, shortest RR interval ≦220 ms during spontaneous atrial fibrillation (AF), inducibility of supraventricular tachycardias, ventricular effective refractory period ≦190 ms, mean shortest RR interval during induced AF ≦, 180 ms and presence of multiple accessory pathways. Data from this retrospective study indicate that: (1) the anterograde conduction properties of the accessory pathway are a major determinant of the occurrence of VF in the WPW syndrome; (2) other markers for risk of VF are type of previously documented supraventricular tachyarrhythmia, documentation of more than one type of supraventricular tachycardia in the same patient and presence of two or more accessory pathways; (3) the finding of intermittent pre-excitation and a shortest RR interval during spontaneous AF longer than 220 ms, identifies a group of patients at low risk of VF.

KW - Accessory pathway

KW - Atrial fibrillation

KW - Sudden cardiac death

KW - Ventricular fibrillation

KW - Wolff-Parkin son -White syndrome

UR - http://www.scopus.com/inward/record.url?scp=0026065846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026065846&partnerID=8YFLogxK

M3 - Article

C2 - 2044547

AN - SCOPUS:0026065846

VL - 12

SP - 144

EP - 150

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 2

ER -